Tocqueville Asset Management L.P. Raises Position in Definitive Healthcare Corp. $DH

Key Points

• Tocqueville Asset Management L.P. increased its stake in Definitive Healthcare Corp. by 32.5%, owning 265,000 shares valued at approximately $766,000 as of the latest quarter.
• Definitive Healthcare's stock has experienced a one-year range between $2.15 and $5.68, and currently has a market capitalization of $553.95 million.
• Recent analyst ratings for Definitive Healthcare show a mix of opinions, with one analyst upgrading the stock to a "buy" rating, while others maintain "hold" or "neutral" ratings and an average price target of $4.73.

Tocqueville Asset Management L.P. raised its stake in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 32.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 265,000 shares of the company's stock after acquiring an additional 65,000 shares during the quarter. Tocqueville Asset Management L.P. owned approximately 0.25% of Definitive Healthcare worth $766,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Bayesian Capital Management LP acquired a new position in shares of Definitive Healthcare in the fourth quarter worth $41,000. Two Sigma Securities LLC acquired a new position in shares of Definitive Healthcare in the fourth quarter worth $56,000. ProShare Advisors LLC raised its holdings in shares of Definitive Healthcare by 49.1% in the fourth quarter. ProShare Advisors LLC now owns 15,018 shares of the company's stock worth $62,000 after acquiring an additional 4,943 shares during the last quarter. Cerity Partners LLC acquired a new position in shares of Definitive Healthcare in the first quarter worth $56,000. Finally, Price T Rowe Associates Inc. MD raised its holdings in shares of Definitive Healthcare by 20.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 20,572 shares of the company's stock worth $85,000 after acquiring an additional 3,496 shares during the last quarter. 98.67% of the stock is owned by institutional investors and hedge funds.

Definitive Healthcare Trading Up 7.7%

DH stock traded up $0.29 during trading on Friday, reaching $4.06. 367,584 shares of the stock traded hands, compared to its average volume of 464,491. The business's 50 day moving average price is $3.93 and its 200-day moving average price is $3.55. Definitive Healthcare Corp. has a 52-week low of $2.15 and a 52-week high of $5.68. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.65 and a quick ratio of 1.65. The firm has a market capitalization of $581.15 million, a PE ratio of -1.53, a P/E/G ratio of 5.38 and a beta of 1.64.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the company. The Goldman Sachs Group lifted their price objective on Definitive Healthcare from $3.00 to $3.40 and gave the company a "neutral" rating in a research report on Monday, May 12th. Robert W. Baird set a $4.00 price objective on Definitive Healthcare in a research report on Friday, August 8th. Wall Street Zen raised Definitive Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, June 21st. BTIG Research downgraded Definitive Healthcare from a "buy" rating to a "neutral" rating in a research report on Friday, May 9th. Finally, Stifel Nicolaus lifted their price objective on Definitive Healthcare from $5.00 to $6.00 and gave the company a "buy" rating in a research report on Friday, August 8th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $4.73.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.